Fundamental basis of atherosclerosis disease;Données fondamentales sur l'athérosclérose

Annales d'Endocrinologie

Volumn 62, Issue 2, 2001, Pages 93-100

  Fruchart, J Ch ^a   Duriez, P ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Atherosclerosis; Risk factor; Stroke

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLONY STIMULATING FACTOR 1; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; DEATH; DIABETES MELLITUS; DNA MICROARRAY; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDUSTRIALIZATION; INFLAMMATORY DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; REVIEW; SMOKING; STROKE;

ANIMALS; ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; ENVIRONMENT; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0035099996     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA: Cholesterol acyltransferase 1
2. Coronary heart disease: Reducing the risk : The scientific background to primary and secondary prevention of coronary heart disease. A worldwide view
3. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding
4. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
5. Characterization of single-nucleotide polymorphisms in coding regions of human genes
6. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice
7. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
8. The combined role of P- and E-selectins in atherosclerosis
9. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
10. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
11. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet
12. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
13. Homocysteine and atherosclerosis
14. Vascular endothelium, hemodynamic forces, and atherogenesis
15. Depression and the course of coronary artery disease
16. Genetic aspects of arteriosclerosis
17. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
18. High-density lipoprotein - The clinical implications of recent studies
19. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
20. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
21. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo
22. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
23. Paraoxonase genes and disease
24. RAGE mediates a novel proinflammatory axis : A central cell surface receptor for S100/calgranulin polypeptides
25. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
26. Role of group II secretory phospholipase A2 in atherosclerosis : 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
27. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
28. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis : Prospective results from the Bruneck study
29. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings
30. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease
31. Changing concepts of atherogenesis
32. Molecular genetics of human hypertension
33. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix
34. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model
35. Estrogens and atherosclerosis
36. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy
37. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
38. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
39. The pathogenesis of atherosclerosis: A perspective for the 1990s
40. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells
41. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
42. Proliferation and the monoclonal origins of atherosclerotic lesions
43. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
44. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
45. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet
46. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.
47. Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension
48. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration
49. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
50. Ultrastructure of early lipid accumulation in ApoE-deficient mice
51. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
52. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
53. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify
54. The ABCs of cholesterol efflux